|
SE0100172D0
(sv)
|
2001-01-22 |
2001-01-22 |
Ulf Nilsson |
New inhibitors against galectins
|
|
SE0401300D0
(sv)
|
2004-05-21 |
2004-05-21 |
Forskarpatent I Syd Ab |
Novel Galactoside Inhibitors of Galectins
|
|
SE0401301D0
(sv)
|
2004-05-21 |
2004-05-21 |
Forskarpatent I Syd Ab |
Novel 3-triazolyl-galactoside inhibitors of galectins
|
|
EP2620443A1
(en)
|
2012-01-25 |
2013-07-31 |
Galecto Biotech AB |
Novel galactoside inhibitors of galectins
|
|
US8828971B2
(en)
|
2012-10-10 |
2014-09-09 |
Galectin Therapeutics, Inc. |
Galactose-pronged carbohydrate compounds for the treatment of diabetic nephropathy and associated disorders
|
|
JP2015535233A
(ja)
|
2012-10-31 |
2015-12-10 |
ガレクト・バイオテック・エイビイ |
ガレクチン−３のガラクトシド阻害剤及び肺線維症のためのその使用
|
|
WO2014078655A1
(en)
|
2012-11-15 |
2014-05-22 |
Tufts University |
Methods, compositions and kits for treating, modulating, or preventing ocular angiogenesis or fibrosis in a subject using a galectin protein inhibitor
|
|
JP6904906B2
(ja)
|
2015-01-30 |
2021-07-21 |
ガレクト・バイオテック・エイビイ |
ガレクチンの新規なガラクトシド阻害剤
|
|
KR101974793B1
(ko)
|
2015-07-06 |
2019-05-02 |
길리애드 사이언시즈, 인코포레이티드 |
Cot 조정제 및 그의 사용 방법
|
|
BR112018007161B1
(pt)
*
|
2015-10-09 |
2024-01-16 |
Galapagos Nv |
COMPOSTOS PIRAZOLO[3,4-b]PIRIDIN-6-CARBOXAMIDA N-SULFONILADA, COMPOSIÇÃO FARMACÊUTICA CONTENDO OS DITOS COMPOSTOS E USOS DOS MESMOS PARA TRATAR FIBROSE CÍSTICA
|
|
CA3025867A1
(en)
|
2016-07-12 |
2018-01-18 |
Galecto Biotech Ab |
Alpha-d-galactoside inhibitors of galectins
|
|
US20200061095A1
(en)
|
2017-05-12 |
2020-02-27 |
Galectin Sciences, Llc |
Compounds for the Treatment of Systemic Insulin Resistance Disorders and the Use Thereof
|
|
CA3062648A1
(en)
|
2017-05-12 |
2018-11-15 |
Galectin Sciences, Llc |
Compounds for the prevention and treatment of diseases and the use thereof
|
|
WO2019067702A1
(en)
|
2017-09-27 |
2019-04-04 |
Bristol-Myers Squibb Company |
INHIBITORS WITH SMALL MOLECULES OF GALECTIN-3
|
|
WO2019075045A1
(en)
|
2017-10-11 |
2019-04-18 |
Bristol-Myers Squibb Company |
INHIBITORS WITH SMALL MOLECULES OF GALECTIN-3
|
|
AU2018361991A1
(en)
*
|
2017-10-31 |
2020-05-14 |
Galectin Sciences, Llc |
Selenogalactoside compounds for the treatment of systemic insulin resistance disorders and the use thereof
|
|
JP2022508719A
(ja)
|
2018-10-15 |
2022-01-19 |
ガレクト バイオテック エービー |
ガレクチンのガラクトシド阻害剤のプロドラッグ
|
|
CN113366007A
(zh)
|
2018-10-15 |
2021-09-07 |
格莱克特生物技术公司 |
半乳糖凝集素的半乳糖苷抑制剂
|
|
JP7486484B2
(ja)
|
2018-11-21 |
2024-05-17 |
ガレクト バイオテック エービー |
ガレクチンのα－Ｄ－ガラクトシド阻害剤
|
|
EP3953349A1
(en)
|
2019-04-10 |
2022-02-16 |
Bristol-Myers Squibb Company |
Small molecule inhibitors of galectin-3
|
|
CA3141436A1
(en)
|
2019-07-03 |
2021-01-07 |
Fredrik Zetterberg |
Novel galactoside inhibitor of galectins
|
|
CN114450282A
(zh)
|
2019-07-05 |
2022-05-06 |
格莱克特生物技术公司 |
半乳糖凝集素的新型半乳糖苷抑制剂
|
|
CN114206893A
(zh)
|
2019-08-09 |
2022-03-18 |
爱杜西亚药品有限公司 |
(杂)芳基-甲基-硫代-β-D-吡喃半乳糖苷衍生物
|
|
JP7604457B2
(ja)
|
2019-08-15 |
2024-12-23 |
イドルシア・ファーマシューティカルズ・リミテッド |
２－ヒドロキシシクロアルカン－１－カルバモイル誘導体
|
|
CA3148365A1
(en)
|
2019-08-29 |
2021-03-04 |
Martin Bolli |
Alpha-d-galactopyranoside derivatives
|
|
ES3014851T3
(en)
|
2020-10-06 |
2025-04-25 |
Idorsia Pharmaceuticals Ltd |
Spiro derivatives of alpha-d-galactopyranosides
|
|
KR20230104190A
(ko)
|
2020-11-02 |
2023-07-07 |
이도르시아 파마슈티컬스 리미티드 |
갈렉틴-3 억제 2-히드록시시클로알칸-1-카르바모일 유도체
|
|
KR20230145111A
(ko)
|
2021-02-09 |
2023-10-17 |
이도르시아 파마슈티컬스 리미티드 |
히드록시헤테로시클로알칸-카르바모일 유도체
|
|
PL4301748T3
(pl)
|
2021-03-03 |
2025-09-08 |
Idorsia Pharmaceuticals Ltd |
Triazolilo-metylo podstawione pochodne alfa-d-galaktopiranozydu
|